November 8-10, 2021 | Virtual Conference

Register Now en English


Brian McCormick

Vice President & Chief Regulatory Counsel Head, Global Regulatory Policy
Teva Pharmaceuticals

Brian McCormick is Vice President, Chief Regulatory Counsel, and Head of Global Regulatory Policy for Teva Pharmaceuticals. Brian and his team provide regulatory law, intelligence, and policy support to Teva’s specialty, generic, biologic, and biosimilar businesses. They counsel clients on a wide range of FDA regulatory matters through all phases of the product lifecycle, and provide strategic advice on the Hatch Waxman Act, the Biologics Price Competition and Innovation Act, the Orphan Drug Act, the Best Pharmaceuticals for Children Act, and other laws. His team manages global regulatory policy and intelligence, supports R&D agreements, oversees the development of approved and promotional labeling, and represents Teva in global trade associations. Previously, Brian was an Assistant General Counsel at a major research-based biopharmaceutical company and a Partner in the FDA regulatory group of an international firm. Brian earned his law degree from Georgetown and has a master’s degree in health policy from Johns Hopkins and a bachelor’s degree in government from Franklin & Marshall College.

Get Started & Register

Whether you are an AAM member, general attendee, or exhibitor, come meet the leaders and decision-makers who are determining the future of generics and biosimilars.

Register Now

Skip to content